Literature DB >> 30991882

NUT midline carcinoma in the right orbit: a case report.

Tingting Ding1, Yajin Wang1, Tai Zhao1, Zhoumin Xu1, Wenwen Gao1, Zhangli Cui1, Yuqing Du1.   

Abstract

Nuclear protein in testis (NUT) midline carcinoma (NMC) is a rare malignant tumor defined by a unique chromosomal translocation of the NUT gene on chromosome 15q14. This very rare tumor is usually located in midline structures, especially in the head and neck region. However, there have been no previous reports of NMC arising from the eyes. Here, we first describe a case of NMC originating in the right orbit of a 60-year-old woman. A multimodality approach, including surgery, chemotherapy, radiotherapy, and target therapy, was adopted in clinical practice.

Entities:  

Keywords:  NUT midline carcinoma; anlotinib hydrochloride; chemotherapy; radiotherapy; right orbit; surgery

Mesh:

Substances:

Year:  2019        PMID: 30991882      PMCID: PMC6606030          DOI: 10.1080/15384047.2019.1598761

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  14 in total

1.  Successful treatment of a child with t(15;19)-positive tumor.

Authors:  Fredrik Mertens; Thomas Wiebe; Catharina Adlercreutz; Nils Mandahl; Christopher A French
Journal:  Pediatr Blood Cancer       Date:  2007-12       Impact factor: 3.167

Review 2.  Pathogenesis of NUT midline carcinoma.

Authors:  Christopher A French
Journal:  Annu Rev Pathol       Date:  2011-10-17       Impact factor: 23.472

3.  NUT midline carcinoma of the parotid gland with mesenchymal differentiation.

Authors:  Michael A den Bakker; Berna H Beverloo; Marry M van den Heuvel-Eibrink; Cees A Meeuwis; Liane M Tan; Laura A Johnson; Christopher A French; Geert J L H van Leenders
Journal:  Am J Surg Pathol       Date:  2009-08       Impact factor: 6.394

4.  NUT gene rearrangement in a poorly-differentiated carcinoma of the submandibular gland.

Authors:  James Ziai; Chris A French; Eduardo Zambrano
Journal:  Head Neck Pathol       Date:  2010-03-30

5.  Differentiation of NUT midline carcinoma by epigenomic reprogramming.

Authors:  Brian E Schwartz; Matthias D Hofer; Madeleine E Lemieux; Daniel E Bauer; Michael J Cameron; Nathan H West; Elin S Agoston; Nicolas Reynoird; Saadi Khochbin; Tan A Ince; Amanda Christie; Katherine A Janeway; Sara O Vargas; Antonio R Perez-Atayde; Jon C Aster; Stephen E Sallan; Andrew L Kung; James E Bradner; Christopher A French
Journal:  Cancer Res       Date:  2011-03-29       Impact factor: 12.701

Review 6.  NUT midline carcinoma: an imaging case series and review of literature.

Authors:  Aruna Polsani; Kiery A Braithwaite; Adina L Alazraki; Carlos Abramowsky; Bahig M Shehata
Journal:  Pediatr Radiol       Date:  2011-10-28

7.  Clinicopathologic features and long-term outcomes of NUT midline carcinoma.

Authors:  Daniel E Bauer; Chelsey M Mitchell; Kelly M Strait; Christopher S Lathan; Edward B Stelow; Sonja C Lüer; Somala Muhammed; Andrew G Evans; Lynette M Sholl; Juan Rosai; Eugenia Giraldi; Richard P Oakley; Carlos Rodriguez-Galindo; Wendy B London; Stephen E Sallan; James E Bradner; Christopher A French
Journal:  Clin Cancer Res       Date:  2012-08-15       Impact factor: 12.531

8.  Midline carcinoma of children and young adults with NUT rearrangement.

Authors:  Christopher A French; Jeffery L Kutok; William C Faquin; Jeffrey A Toretsky; Cristina R Antonescu; Constance A Griffin; Vania Nose; Sara O Vargas; Mary Moschovi; Fotini Tzortzatou-Stathopoulou; Isao Miyoshi; Antonio R Perez-Atayde; Jon C Aster; Jonathan A Fletcher
Journal:  J Clin Oncol       Date:  2004-10-15       Impact factor: 44.544

9.  NUT midline carcinoma in a newborn with multiorgan disseminated tumor and a 2-year-old with a pancreatic/hepatic primary.

Authors:  Bahig M Shehata; Charlotte K Steelman; Carlos R Abramowsky; Thomas A Olson; Christopher A French; Debra F Saxe; Richard R Ricketts; Howard M Katzenstein
Journal:  Pediatr Dev Pathol       Date:  2009-12-17

10.  Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody.

Authors:  Herbert Haack; Laura A Johnson; Christopher J Fry; Katherine Crosby; Roberto D Polakiewicz; Edward B Stelow; Seung-Mo Hong; Brian E Schwartz; Michael J Cameron; Mark A Rubin; Martin C Chang; Jon C Aster; Christopher A French
Journal:  Am J Surg Pathol       Date:  2009-07       Impact factor: 6.394

View more
  1 in total

Review 1.  Advances in the pathogenesis and treatment of nut carcinoma: a narrative review.

Authors:  Sanchun Wang; Jinqiu Li; Weifang Tong; Hejie Li; Qingjie Feng; Bo Teng
Journal:  Transl Cancer Res       Date:  2020-10       Impact factor: 1.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.